Answers are grounded in this paper and cite their sources.
Population-based cohort study reveals higher rates and earlier onset of osteoporosis, cataracts, and osteonecrosis in adults with asthma, suggesting a need for tailored comorbidity screening.
PURPOSE: The adverse effects of corticosteroid therapy in the treatment of asthma have been extensively documented and explored over the past several decades. Prominent among these adverse effects are osteoporosis, cataracts, and osteonecrosis. We assessed the prevalence of these 3 well-known side effects of corticosteroid therapy for asthma in asthmatics versus nonasthmatics from a general adult population of 3.5 million individuals. The objective of the study was to make data-driven recommendations regarding screening for the 3 aforementioned comorbidities in specific asthmatic populations. METHODS: Using the Colorado all payers claims database with dates of service January 1, 2017 through June 30, 2020, we determined the prevalence of osteoporosis, cataracts, and osteonecrosis by asthma severity, age, and sex compared with an age and sex matched nonasthmatic comparator group. FINDINGS: Asthmatics generally showed an earlier onset and higher prevalence of these 3 side effects which correlated with asthma severity, often reaching statistically significant divergence from the nonasthmatic comparator group. Patterns of prevalence with regard to both age and sex were distinctive for each side effect. IMPLICATIONS: Based on our findings, we suggest customized screening guidelines for osteoporosis, cataracts, and osteonecrosis for specific subpopulations of asthmatics as defined by age, sex, and asthma severity.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: